IFITM1 and COVID-19: Our study investigated IFN-I driven inflammation and found that the IFN-I responsive genes (e.g., ISG15 and IFITM1/2/3, etc.)and associated-GO pathways were enriched in COVID-19 patients with acute necrotizing encephalopathy.